Skip to main content
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc. — Investor Relations & Filings

Ticker · SRPT ISIN · US8036071004 LEI · 549300IKDPIED8J8IG21 US Manufacturing
Filings indexed 1,061 across all filing types
Latest filing 2024-06-26 Director's Dealing
Country US United States of America
Listing US SRPT

About Sarepta Therapeutics, Inc.

https://www.sarepta.com/

Sarepta Therapeutics is a commercial-stage biopharmaceutical company that engineers precision genetic medicines for rare diseases. The company's research and development efforts are centered on RNA-targeted therapeutics and gene therapies, with a primary focus on treating rare neuromuscular and central nervous system disorders. Sarepta aims to accelerate the drug development process from discovery to patient application and is building significant gene therapy manufacturing capabilities to support its mission.

Recent filings

Filing Released Lang Actions
4
Director's Dealing
2024-06-26 English
Regulatory Filings 2024
Regulatory Filings
2024-06-25 English
Regulatory Filings 2024
Regulatory Filings
2024-06-25 English
Regulatory Filings 2024
Regulatory Filings
2024-06-24 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 6, 2024. It includes information about an amendment to the company's employment incentive plan and detailed voting results from the company's annual meeting of stockholders held on June 6, 2024. The voting results cover election of directors, advisory vote on executive compensation, and ratification of the independent auditor. The document does not contain full financial statements or comprehensive financial performance data, but rather announcements related to board and management changes and shareholder voting outcomes. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-06-07 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-06-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.